Hca Healthcare Intrinsic Stock Value – HCA Healthcare Shares Soar to New 12-Month High After Analyst Upgrade
July 1, 2023

☀️Trending News
HCA ($NYSE:HCA) Healthcare, Inc. is one of the nation’s leading healthcare companies, providing a wide range of services and treatments through their network of hospitals, surgery centers, home health agencies, and more. On Thursday, HCA Healthcare shares were soaring to a new 12-month high after Barclays upgraded the stock from $275.00 to $290.00. The analyst upgrade gave investors a clear signal that the company and its stock were on an upward trajectory and further solidified the potential of the company for investors. The surge in stock price came as a result of the positive sentiment driven by the analyst upgrade.
Investors were encouraged by the positive outlook on HCA Healthcare’s future, and their enthusiasm resulted in a significant increase in the stock price. This is great news for investors in HCA Healthcare as the stock has now reached a 12-month high of $290.00 and is likely to continue its upward trend in the months ahead. The analyst upgrade has also given the company an increased credibility in the eyes of the market, setting it up for further success.
Market Price
The stock opened at $303.9 and closed at $303.5, an increase of 1.0% from the previous closing price of $300.4. This surge in stock prices came after analysts upgraded their rating of the company. Investors have responded positively to the news, pushing the stock to its 12-month high. With this increase in prices, HCA HEALTHCARE could be in store for more gains in the future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Hca Healthcare. More…
| Total Revenues | Net Income | Net Margin |
| 60.88k | 5.73k | 7.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Hca Healthcare. More…
| Operations | Investing | Financing |
| 8.98k | -3.69k | -6.81k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Hca Healthcare. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 52.71k | 52.48k | -11.87 |
Key Ratios Snapshot
Some of the financial key ratios for Hca Healthcare are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 5.6% | 10.8% | 17.2% |
| FCF Margin | ROE | ROA |
| 7.0% | -249.4% | 12.4% |
Analysis – Hca Healthcare Intrinsic Stock Value
At GoodWhale, we have conducted a deep dive into HCA HEALTHCARE‘s fundamentals. Our proprietary Valuation Line analysis has found that its fair value is around $249.3. This is lower than the current market price of $303.5, showing that the stock is overvalued by 21.8%. We believe this could be an opportunity to take advantage of for potential investors. More…

Peers
HCA Healthcare Inc is a healthcare company that operates in the United States. The company’s competitors include Universal Health Services Inc, Tenet Healthcare Corp, and Community Health Systems Inc.
– Universal Health Services Inc ($NYSE:UHS)
Universal Health Services, Inc. is one of the largest healthcare management companies in the United States. The company owns and operates hospitals, physician groups, ambulatory surgery centers, and other healthcare facilities. Universal Health Services is headquartered in King of Prussia, Pennsylvania.
– Tenet Healthcare Corp ($NYSE:THC)
Tenet Healthcare Corporation is an American for-profit healthcare services company based in Dallas, Texas. through its subsidiaries, the company owns and operates hospitals, outpatient facilities, and Conifer Health Solutions, a health services company. As of February 2021, Tenet operated 79 hospitals and more than 470 outpatient centers in the United States.
– Community Health Systems Inc ($NYSE:CYH)
Community Health Systems Inc (CHS) is a for-profit operator of general acute care hospitals. As of 2022, it has a market capitalization of 311.19 million and a return on equity of -48.01%. The company’s hospitals offer a wide range of services, including emergency care, surgery, laboratory and imaging services. CHS also owns and operates a number of home health, hospice and outpatient facilities.
Summary
HCA Healthcare, Inc. recently hit a new 12-month high after Barclays raised their price target on the stock from $275.00 to an undisclosed amount. This analyst upgrade was seen by many as an indication of a positive outlook for the company and an increase in investor confidence. Analysts have pointed out that HCA Healthcare has a strong balance sheet and cash flow, as well as several potential growth opportunities. This, coupled with the recent analyst upgrade, has made HCA Healthcare a highly attractive investment option for investors.
Recent Posts









